Neurocrine Biosciences
NBIX
#1421
Rank
A$18.85 B
Marketcap
$186.24
Share price
1.61%
Change (1 day)
5.57%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of June 2024 : A$5.03 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are A$5.03 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$4.77 B37.1%
2022-12-31A$3.48 B21.76%
2021-12-31A$2.85 B26.72%
2020-12-31A$2.25 B20.94%
2019-12-31A$1.86 B32.31%
2018-12-31A$1.40 B34.62%
2017-12-31A$1.04 B106.77%
2016-12-31A$0.50 B-22.29%
2015-12-31A$0.65 B119.47%
2014-12-31A$0.29 B71.25%
2013-12-31A$0.17 B-8.05%
2012-12-31A$0.18 B39.75%
2011-12-31A$0.13 B-5.09%
2010-12-31A$0.14 B80.35%
2009-12-31A$78.83 M-52.94%
2008-12-31A$0.16 B-47.06%
2007-12-31A$0.31 B-35.99%
2006-12-31A$0.49 B-25.13%
2005-12-31A$0.66 B-1.59%
2004-12-31A$0.67 B-10.13%
2003-12-31A$0.74 B57.82%
2002-12-31A$0.47 B-30.29%
2001-12-31A$0.67 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$4.36 B-13.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.90 B 434.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$16.37 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$109.53 B 2,074.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$216.29 B 4,194.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$329.45 B 6,441.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.40 B-72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.31 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA